|Articles|September 27, 2018

ActiGraph Launches New Activity Monitor

ActiGraph has announced the launch of its newest activity monitor, the CentrePoint Insight Watch. This watch hopes to deliver high quality, real-world data, and an enhance patient experiences during clinical drug trials and health research studies.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

ActiGraph Launches New Activity Monitor

Related Content

Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV

Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad

ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced

The CRA of the Future: From Monitoring Activity to Strategic Site Partnership

Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data

Trending on Applied Clinical Trials Online

Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program

The CRA of the Future: From Monitoring Activity to Strategic Site Partnership

ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps

Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work

Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad